Form 4 for IGC IGC Pharma, Inc.
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-20 · accession 0001185185-21-001876 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-23 | 2021-12-20 | IGC | MUKUNDA RAM | CEO, Dir | A - Grant | — | 0 | 2.17M | New | — |
| DI | 2021-12-23 | 2021-12-20 | IGC | MUKUNDA RAM | CEO, Dir | A - Grant | — | 0 | 727.4K | New | — |
| DI | 2021-12-23 | 2021-12-20 | IGC | MUKUNDA RAM | CEO, Dir | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| DM | 2021-12-23 | 2021-12-20 | IGC | MUKUNDA RAM | CEO, Dir | A - Grant | $0.00 | +4.20M | 1.00M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | A | A | 0 | $0.00 | 2,174,760 | D BY SPOUSE | — | — | (F1) RSUs subject to vesting equally over three years starting on March 31, 2022. (F2) Corrects a previous Section 16 May 14, 2021, filing, which overstated the ownership of non-derivative securities by 1,000,000 shares. |
| 2 | Common | Common Stock | 2021-12-20 | A | A | 0 | $0.00 | 727,417 | I | — | — | (F4) RSUs subject to vesting equally over three years starting on March 31, 2022. (F5) Corrects a previous Section 16 May 14, 2021, filing, which overstated the ownership of non-derivative securities by 50,000 shares |
| 3 | Derivative | Restricted Stock Units | 2021-12-20 | A | A | 50,000 | $0.00 | 50,000 | I | $0.00 · 2022-03-31 to 2024-04-01 | 50,000 Common Stock | (F4) RSUs subject to vesting equally over three years starting on March 31, 2022. |
| 4 | Derivative | Restricted Stock Units | 2021-12-20 | A | A | 3,200,000 | $0.00 | 4,200,000 | D | $0.00 · — to — | 3,200,000 Common Stock | (F3) RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs do not have an exercisable or expiration date. The RSUs vest when milestones are achieved. |
| 5 | Derivative | Restricted Stock Units | 2021-12-20 | A | A | 1,000,000 | $0.00 | 1,000,000 | D BY SPOUSE | $0.00 · 2022-03-31 to 2024-04-01 | 1,000,000 Common Stock | (F1) RSUs subject to vesting equally over three years starting on March 31, 2022. |